FDA moves to real-time clinical trial patient monitoring, faster drug review
The U.S. Food and Drug Administration (FDA) is moving to speed drug development and review by launching real-time clinical trials.
Apr 29, 2026
0
4
Hemic and Lymphatic Diseases: News and Research on Lymphoproliferative Disorders
MeSH tree: C15.604.515
Rethinking mRNA vaccines: Liver targeting can suppress immunity, while muscle boosts it
A new study by researchers at the Icahn School of Medicine at Mount Sinai overturns a longstanding assumption about how mRNA vaccines generate immunity, revealing that certain non-immune cells help determine vaccine effectiveness.
Apr 29, 2026
0
30
Discovery of a novel vulnerability in aggressive lymphoma could change future therapy
A research team at the University of Cologne's Center for Molecular Medicine Cologne (CMMC) has discovered that the protein cFLIP can be used to override the defenses of Diffuse Large B Cell Lymphoma (DLBCL) against programmed ...
Apr 26, 2026
0
12
Understanding the origins of Hodgkin lymphoma cells could lead to better diagnostics
For the first time, Weill Cornell Medicine researchers have demonstrated that Hodgkin lymphoma cancer cells from patient samples are immune cells stuck in an "identity crisis." Normally, a B cell matures into a plasma cell ...
Apr 24, 2026
0
7
PET biomarker outperforms established risk score in predicting survival for large B-cell lymphoma patients
Metabolic tumor volume—a biomarker derived from PET imaging—can more accurately predict progression-free survival for large B-cell lymphoma patients than the widely used International Prognostic Index. By identifying patients ...
Apr 22, 2026
0
1
Protective 'switch' in most common blood cancer opens new doors for diagnosis and treatment
A new study published in The Journal of Immunology by researchers at the Josep Carreras Leukaemia Research Institute (IJC) has uncovered a crucial biological "off switch" in diffuse large B cell lymphoma (DLBCL), the most ...
Apr 20, 2026
0
11
Teen and young adult cancer survivors face double the risk of later cancers, finds study
Survivors of cancer in their teen and young adult years are at double the risk of most types of later cancers, according to research from Alberta published in the Canadian Medical Association Journal. Primary neoplasms—new ...
Apr 13, 2026
0
4
Advanced CT scan analysis may help identify different forms of sarcoidosis
Researchers have identified a new method for analyzing chest CT scans that may help physicians better understand the different forms of sarcoidosis, a complex inflammatory lung disease that affects more than 150,000 people ...
Apr 10, 2026
0
5
How an overactive immune system can drive cancer
The immune system is designed to protect us against viruses and bacteria. In autoimmune diseases, however, the immune system instead attacks the body's own cells. Conditions such as systemic lupus erythematosus (lupus) and ...
Apr 9, 2026
0
13
Data platform unifies blood cancer 'omics' and clinical data to accelerate discovery
Scientists at St. Jude Children's Research Hospital, the American Society for Hematology (ASH) and the Munich Leukemia Laboratory have developed a data-sharing platform that unites genomics, gene expression and clinical information ...
Apr 6, 2026
0
4
